Correction to: Leukemia https://doi.org/10.1038/s41375-022-01620-2, published online 22 June 2022

At the time of original publication, there was an incomplete listing of contributing authors and their institutions. This revision corrects those omissions.

  1. 1.

    Dr Ritsuro Suzuki, Department of Hematology & Oncology, Shimane University School of Medicine, Shimane, Japan, was regrettably omitted from the main author list;

  2. 2.

    Dr Arianna Di Napoli, Department of Clinical and Molecular Medicine, Sapienza University, School of Medicine and Psychology, Sant’Andrea Hospital, Rome, Italy, was incorrectly included as a contributor in the author contribution list, and instead should be a coauthor in the main author list;

  3. 3.

    Dr Luis M. Allende, a contributor in the author contribution list, was assigned with an incorrect affiliation, and the correct affiliation is 70 Immunology Department, Hospital 12 de Octubre, imas12, Madrid, Spain;

  4. 4.

    Dr Aanchal Kakkar, a contributor in the author contribution list, was assigned with an incorrect affiliation, and the correct affiliation is Pathology, All India Institute of Medical Sciences, New Delhi, India.

The above errors have been corrected, and the corrected list of the authors and contributors and their affiliations are as follows.

Rita Alaggio1, Catalina Amador2, Ioannis Anagnostopoulos3, Ayoma D. Attygalle4, Iguaracyra Barreto de Oliveira Araujo5, Emilio Berti6, Govind Bhagat7, Anita Maria Borges8, Daniel Boyer9, Mariarita Calaminici10, Amy Chadburn11, John K.C. Chan12, Wah Cheuk12, Wee-Joo Chng13, John K. Choi14, Shih-Sung Chuang15, Sarah E. Coupland16, Magdalena Czader17, Sandeep S. Dave18, Daphne de Jong19, Arianna Di Napoli,20 Ming-Qing Du21*, Kojo S. Elenitoba-Johnson22, Judith Ferry23*, Julia Geyer11, Dita Gratzinger24, Joan Guitart25, Sumeet Gujral26, Marian Harris27, Christine J. Harrison28, Sylvia Hartmann29, Andreas Hochhaus30, Patty M. Jansen31, Kennosuke Karube32, Werner Kempf33, Joseph Khoury34, Hiroshi Kimura35, Wolfram Klapper36, Alexandra E. Kovach37, Shaji Kumar38, Alexander J. Lazar39, Stefano Lazzi40, Lorenzo Leoncini40, Nelson Leung41, Vasiliki Leventaki42, Xiao-Qiu Li43, Megan S. Lim22, Wei-Ping Liu44, Abner Louissaint Jr.23, Andrea Marcogliese45, L. Jeffrey Medeiros34, Michael Michal46, Roberto N. Miranda34, Christina Mitteldorf47, Santiago Montes-Moreno48, William Morice49, Valentina Nardi23, Kikkeri N. Naresh50, Yasodha Natkunam24, Siok-Bian Ng51, Ilske Oschlies36, German Ott52*, Marie Parrens53, Melissa Pulitzer54, S. Vincent Rajkumar55, Andrew C. Rawstron56, Karen Rech49, Andreas Rosenwald3, Jonathan Said57, Clémentine Sarkozy58, Shahin Sayed59, Caner Saygin60, Anna Schuh61, William Sewell62, Reiner Siebert63*, Aliyah R. Sohani23, Ritsuro Suzuki64, Reuben Tooze65, Alexandra Traverse-Glehen66, Francisco Vega34, Beatrice Vergier67, Ashutosh D. Wechalekar68, Brent Wood37, Luc Xerri69, Wenbin Xiao54

1Pathology Unit, Department of Laboratories, Bambino Gesu Children’s Hospital, IRCCS, Rome, Italy;

2Department of Pathology, University of Miami, Miami, FL, USA;

3Institute of Pathology, Julius-Maximilians-Universität Würzburg, Würzburg, Germany;

4Department of Histopathology, Royal Marsden Hospital, London, UK;

5Department of Pathology, Federal University of Bahia (UFBA), Salvador, Brazil;

6University of Milan, Fondazione Cà Granda, IRCCS, Ospedale Maggiore Policlinico, Milan, Italy;

7Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, USA;

8Division of Histopathology, SL Raheja Hospital, Mumbai, India;

9Department of Pathology, University of Michigan, Ann Arbor, MI, USA;

10Centre for Haemato-Oncology, Barts Cancer institute, QMUL and SIHMDS Barts Health NHS Trust, London, UK;

11Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA;

12Department of Pathology, Queen Elizabeth Hospital, Kowloon, Hong Kong;

13National University Cancer Institute, Singapore, Singapore;

14Department of Pathology, The University of Alabama at Birmingham, Birmingham, AL, USA

15Department of Pathology, Chi-Mei Medical Center, Tainan, Taiwan;

16Liverpool Clinical Laboratories, Liverpool University Hospitals Foundation Trust, Liverpool, UK;

17Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN, USA;

18Center for Genomic and Computational Biology and Department of Medicine, Duke University, Durham, NC, USA

19Amsterdam UMC, location Vrije Universiteit Amsterdam, Department of Pathology, Amsterdam, The Netherlands;

20Department of Clinical and Molecular Medicine, Sapienza University, School of Medicine and Psychology, Sant’ Andrea Hospital, Rome, Italy;

21Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge, UK;

22Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA;

23Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA;

24Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA;

25Department. of Dermatology, Northwestern University Feinberg Medical School, Chicago, IL, USA;

26Department of Pathology, Tata Memorial Hospital, Mumbai, India;

27Department of Pathology, Boston Children’s Hospital, Boston, MA, USA;

28Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle-upon-Tyne, UK;

29Dr. Senckenberg Institute of Pathology, Goethe University Frankfurt, Frankfurt am Main, Germany;

30Hematology/Oncology, Universitätsklinikum Jena, Jena, Germany;

31Leiden University Medical Center, Department of Pathology, Leiden, The Netherlands;

32Department of Pathology and Laboratory Medicine, Nagoya, Japan;

33Kempf und Pfaltz Histologische Diagnostik Zurich, and Department of Dermatology, University Hospital Zurich, Zurich, Switzerland;

34Department of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;

35Department of Virology, Nagoya University Graduate School of Medicine, Nagoya, Japan;

36Department of Pathology, Hematopathology Section and Lymph Node Registry, University Hospital Schleswig-Holstein, University of Kiel, Kiel, Germany;

37Department of Pathology and Laboratory Medicine, Children’s Hospital Los Angeles, Los Angeles, CA, USA;

38Division of Hematology, Mayo Clinic, Rochester, MN, USA;

39Departments of Pathology & Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;

40Department of Medical Biotechnology, University of Siena, Siena, Italy;

41Division of Nephrology and Hypertension, Division of Hematology, Mayo Clinic, Rochester, MN, USA;

42Department of Pathology, Medical College of Wisconsin and Children’s Wisconsin, Milwaukee, WI, USA;

43Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, PR China;

44Department of Pathology, West-China Hospital, Sichuan University, Chengdu, PR China;

45Department of Pathology & Immunology, Baylor College of Medicine and Texas Children’s Hospital, Houston, TX, USA;

46Department of Pathology, Charles University in Prague, Faculty of Medicine in Plzen, Plzen, Czech Republic;

47Department of Dermatology, Venereology and Allergology, University Medical Center Göttingen, Göttingen, Germany;

48Anatomic Pathology Department and Translational Hematopathology Lab, Valdecilla/IDIVAL University Hospital, Santander, Spain;

49Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA;

50Section of Pathology, Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA;

51Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore;

52Department of Clinical Pathology, Robert-Bosch-Krankenhaus, and Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany;

53Department of Pathology, Bordeaux University Hospital, Bordeaux, France;

54Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA;

55Division of Hematology, Mayo Clinic, Rochester, Minnesota, Rochester, MN, USA;

56HMDS, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK;

57Department of Pathology and Laboratory Medicine, University of California Los Angeles, Los Angeles, CA, USA;

58Institut Curie, Hematology department, Saint Cloud, France;

59Department of Pathology—Aga Khan University Hospital—Nairobi, Nairobi, Kenya;

60Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA;

61Department of Oncology, University of Oxford, Oxford, UK;

62Immunology Division, Garvan Institute of Medical Research, Sydney, NSW, Australia;

63Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany;

64Department of Hematology & Oncology, Shimane University School of Medicine, Shimane, Japan;

65Division of Haematology and Immunology, Leeds Institute of Medical Research, University of Leeds, Leeds, UK;

66Hospices Civils de Lyon/Department of Pathology/Université Lyon 1/Centre International de Recherche en Infectiologie (CIRI) INSERM U1111—CNRS UMR5308, Lyon, France;

67Department of Pathology, Hopital Haut-Lévêque, CHU Bordeaux, Pessac, France;

68National Amyloidosis Centre, University College London, London, UK;

69Department of Pathology, Institut Paoli-Calmettes and Aix-Marseille University, Marseille, France;

AUTHOR CONTRIBUTIONS

JK and AJL are standing members of the WHO Classification of Tumours editorial board. RA, JKCC, WJC, SEC, SSD, DDJ, MQD, JF, SG, AH, MSL, KNN, GO, SS, AS, WS, RSi and BW are expert members of the Haematolymphoid Tumours 5th edition blue book editorial board. CA, IA, ADA, IBOA, EB, GB, AMB, DB, MC, AC, WC, JKC, SSC, MC, AND, KSEJ, JG, DG, JG, MH, CJH, SH, PMJ, KK, WK, HK, WK, AEK, SK, SL, LL, NL, VL,XQL, WPL, ALj, AM, LJM, MM, RNM, CM, SMM, WM, VN, YN, SBN, IO, MP, MP, SVJ, ACR, KR, AR, JS, CS, CS, ARS, RSu, RT, ATG, FV, BV, ADW, LX and WX contributed as responsible authors in the book. All authors and editors contributed to discussions on the content of the book chapters. All listed authors edited and approved the manuscript.

The following colleagues are acknowledged for their expert contributions as authors in the WHO Classification of Haematolymphoid Tumours blue book on lymphoid topics, mesenchymal lesions specific to lymph node and spleen, and germline predisposition syndromes associated with the lymphoid neoplasms. Their affiliations were provided as given in the International Agency for Research on Cancer (IARC) databases. Where authors are identified as personnel of IARC/World Health Organization, the authors alone are responsible for the views expressed in this article, and they do not necessarily represent the decisions, policy, or views of the International Agency for Research on Cancer/World Health Organization.

Norah Olubunmi Akinola70, Yassmine Akkari71, Luis M. Allende72, Katsuyuki Aozasa73, Iguaracyra Araujo74, Luca Arcaini75, Kirit M. Ardeshna76, Naoko Asano77, Andishe Attarbaschi78, Chris M. Bacon28, Sharon Louise Barrans56, Tracy Batchelor79, Maxime Battistella80, Linda B. Baughn49, Amir Behdad81, Sigbjørn Berentsen82, Giada Bianchi83, Jacob Bledsoe27, Peter Borchmann84, Mark Bower85, Barbara Buldini86, Jan Andreas Burger87, Birgit Burkhardt88, Ryan D. Cassaday89, Giovanni Cazzaniga90, Nadine Cerf-Bensussan91, Ethel Cesarman11, Mammen Chandy92, Jennifer R. Chapman93, Björn Chapuy94, Xueyan Chen95, Chee Leong Cheng96, Carlos Chiattone97, Nicholas Chiorazzi98, Lucy B. Cook99, Wendy A. Cooper100, Gregory Philip Corboy101, Andrew John Cowan89, Immacolata Cozzolino102, Ian A Cree103, Emanuele S.G. d’Amore104, Andrew John Davies105, Martina Deckert106, Jan Delabie107, Elizabeth G. Demicco107, Vikram Deshpande23, Arjan Diepstra108, Daan Dierickx109, Kieron Dunleavy110, Barbara Eichhorst111, Daisuke Ennishi112, David C. Fajgenbaum113, Pedro Farinha114, Carlos Fernández de Larrea115, Kevin E. Fisher45, Jude Fitzgibbon116, Melina Flanagan117, Jonathan Fromm95, Juan F. Garcia118, William Robert Geddie107, Morie Gertz38, Ajay Gopal89, Satish Gopal119, Patricia Theresa Greipp49, Alejandro Gru120, Ritu Gupta121, Martin-Leo Hansmann122, Konnie M. Hebeda123, Klaus Herfarth124, Marco Herling125, Olivier Hermine126, Khe Hoang-Xuan127, Jennelle Hodge128, Shimin Hu34, Yuhua Huang129, Yin Pun Hung23, Stephen Hunger130, Hiroto Inaba131, Hiroshi Inagaki132, Javeed Iqbal133, Kenji Ishitsuka134, Noriko Iwaki135, Keiji Iwatsuki136, Nitin Jain87, Yoon Kyung Jeon137, Marshall Kadin138, Sachiko Kaji139, Aanchal Kakkar121, Anastasios Karadimitris140, Keisuke Kataoka141, Seiichi Kato142, Marie José Kersten143, Rhett P. Ketterling49, Ji Eun Kim144, Christian P. Kratz145, Robert Kridel146, Sigurdur Kristinsson147, Ralf Küppers148, Isinsu Kuzu149, Yok-Lam Kwong150, Ann Lacasce151, Laurence Lamant-Rochaix152, Thierry Lamy153, Ola Landgren154, Siddhartha Laskar155, William Bradlyn Laskin156, Georg Lenz157, Shaoying Li34, Gan Di Li44, Pei Lin34, Franco Locatelli158, Robert Brian Lorsbach159, Izidore Lossos154, Thomas P. Jr Loughran160, William R. Macon49, Joseph J. Maleszewski49, Pankaj Malhotra161, Teresa Marafioti162, Dai Maruyama163, Alexander Marx164, Sam M. Mbulaiteye165, Veronique Meignin80, Ester Mejstrikova166, Pamela Michelow167, Markku Miettinen168, Rodney R. Miles169, Hiroaki Miyoshi170, Thierry Jo Molina171, Manuela Mollejo172, Shuji Momose173, Tetsuya Mori174, William G. Morice49, Bertrand Nadel175, Hirokazu Nagai176, Motoo Nagane177, Reena Nair92, Naoya Nakamura178, Atsuko Nakazawa179, Samih Nasr49, Andrew Gordon Nicholson180, Alina Nicolae181, Robert Shigeo Ohgami182, Naoki Oishi183, Timothy S. Olson130, Nicolas Ortonne184, Bruno Paiva185, Qiang Pan-Hammarström186, Mayur Parihar187, Marco Paulli188, Andrea Petersen189, Jennifer Picarsic190, Alessandro Pileri191, Nicola Pimpinelli192, Jose A Plaza193, Karen R. Rabin194, Markus Raderer195, Kanti Rai196, Ulla Randen197, Huilan Rao129, Alistair Robson198, Rosemary Rochford199, Richard Rosenquist200, Davide Rossi201, Esther D. Rossi202, Simon Rule203, Grzegorz Rymkiewicz204, Elena Sabattini205, Vaskar Saha206, Mamiko Sakata-Yanagimoto207, Christian A. Sander208, J. Martin Sangueza209, Omar P. Sangüeza210, Marco Santucci211, Yasuharu Sato212, Akira Satou142, Kristian Theo Schafernak213, Fernando Schmitt214, Gianpietro Semenzato215, Manju Sengar92, Tait Shanafelt216, Kazuyuki Shimada217, Graham W. Slack114, Susan Slager218, Riccardo Soffietti219, David A. Solomon182, Kostas Stamatopoulos220, Christian Steidl221, Stephan Stilgenbauer222, Narittee Sukswai223, Kengo Takeuchi224, Giovanni Tallini225, Junichi Tamaru226, Soo-Yong Tan51, Prashant Tembhare227, Enrico Tiacci228, Yoshiki Tokura229, Olivier Tournilhac230, Steven Treon231, Lorenz Truemper232, Kunihiro Tsukasaki233, Frits van Rhee234, Abraham Varghese235, Maarten H. Vermeer236, Philippe Vielh237, Brian Walker238, Michael Wang239, Huan-You Wang240, Zhe Wang241, Takashi Watanabe242, Oliver Weigert243, David Weinstock244, Sean J. Whittaker245, Rein Willemze236, Wilhelm Woessmann246, Catherine J. Wu244, Motoko Yamaguchi247, Hidetaka Yamamoto248, Daisuke Yamashita249, Shenmiao Yang250, David T Yang251, Takahiko Yasuda252, Wei-Hua Yin253, Yoh Zen254, Sha Zhao44, Wei-Li Zhao255

70Haematology and Immunology, Obafemi Awolowo University, Ile Ife, Nigeria;

71Cytogenetics and Molecular Pathology, Legacy Health, Portland, OR, USA;

72Immunology Department, Hospital 12 de Octubre, imas12, Madrid, Spain;

73Department of Pathology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan;

74Pathology and Forensic Medicine, Federal University of Bahia, Salvador, Bahia, Brazil;

75Fondazione IRCCS Policlinico San Matteo and Departement of Molecular Medicine, University of Pavia, University of Pavia, Pavia, Italy;

76Cancer Division, University College London Hospitals, London, UK;

77Molecular Diagnostics, Nagano Prefectural Shinshu Medical Center, Suzaka, Japan;

78Pediatric Hematology and Oncology, St. Anna Children’s Hospital, Vienna, Austria;

79Department of Neurology, Brigham and Women’s Hospital, Boston MA, USA;

80Pathology Department, Hôpital Saint Louis, AP-HP Université Paris, Paris, France;

81Department of Pathology, Northwestern University, Chicago, IL, USA;

82Department of Research and Innovation, Helse Fonna Hospital Trust, Haugesund, Norway;

83Division of Hematology, Department of Medicine, Brigham and Women’s Hospital, Boston MA, USA;

841st Dept of Internal Medicine, University Hospital of Cologne, Cologne, Germany;

85National Centre for HIV Malignancy, Chelsea & Westminster Hospital, London, UK;

86Maternal and Child’s Health Department, University of Padova, Padova, Italy;

87Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;

88Pediatric Hematology, Oncology and BMT, University Hospital Muenster, Muenster, Germany;

89Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA;

90Pediatrics and Medical Genetics, Univ Milan Bicocca—Centro Ricerca Tettamanti, Barzano, Italy;

91Laboratory Intestinal Immunity, Institut Imagine-Inserm U1183, Université de Paris, Paris, France;

92Clinical Hematology & Medical Oncology, Tata Medical Center, Kolkata, India;

93Pathology and Laboratory Medicine, University of Miami, Miami, FL, USA;

94Hematology, Oncology and Tumor Immunology, Charité, University Medical Center Berlin, Berlin, Germany;

95Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA;

96Anatomical Pathology, Singapore General Hospital, Singapore, Singapore;

97Hematology and Oncology, Santa Casa Midical School, Sao Paulo, Brazil;

98Karches Center for Oncology Research, The Feinstein Institutes for Medical Research, Manhasset, NY, USA;

99Department of Haematology, Imperial College Healthcare NHS Trust, London, UK;

100Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, NSW Health Pathology, Camperdown, NSW, Australia;

101Department of Haematology, Pathology Queensland, Herston, QLD, Australia;

102Pathology Unit, Department of Mental and Physical Health and Preventive Medicine, University of Campania “L. Vanvitelli”, Naples, Italy

103Evidence Synthesis and Classification Branch, International Agency for Research on Cancer, Lyon, France;

104UOC di Anatomia Patologica, Ospedale San Bortolo, Vicenza, Italy;

105Cancer Sciences Unit, University of Southampton, Southampton, UK;

106Department of Neuropathology, University Hospital of Cologne, Cologne, Germany;

107Laboratory Medicine Program, University Health Network and University of Toronto, Toronto, ON, Canada;

108Pathology and Laboratory Medicine, University Medical Center Groningen, Groningen, The Netherlands;

109Department of Hematology, University Hospitals Leuven, Leuven, Belgium;

110Hematology and Oncology, Lombardi Cancer Center, Georgetown University, Washington, DC, USA;

111Department I for Internal Medicine and Center for Integrated Oncology Aachen, Bonn, Cologne, Duesseldorf, University of Cologne, Cologne, Germany;

112Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan;

113Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA;

114Department of Pathology, BC Cancer Agency, Vancouver, BC, Canada;

115Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Clínic of Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain;

116Genomics and Computational Biology, Queen Mary University of London, London, UK;

117Department of Pathology, West Virginia University School of Medicine, Morgantown, WV, USA;

118Department of Pathology, MD Anderson Cancer Center Madrid, Madrid, Spain;

119Center for Global Health, National Cancer Institute, Rockville, MD, USA;

120Pathology & Dermatology, University of Virginia, Charlottesville, VA, USA;

121Laboratory Oncology, All India Institute of Medical Sciences, Delhi, New Delhi, India;

122Consultation Center for Hematopathology, Institute of Pathology and Molecular Pathology, Wuppertal, Germany;

123Department of Pathology, The Radboud University Medical Center, Nijmegen, The Netherlands;

124Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany;

125Hematology, Cellular Therapy, Hemostaseology, University of Leipzig, Leipzig, Germany;

126Hematology and Laboratory of Physiopathology and Treatment of Hematological Disorders, Necker Hospital, APHP, INSERM U1163, Imagine, Paris University, Paris, France;

127Neuro-oncology, Hôpital Universitaire Pitié Salpêtrière, Paris, France;

128Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA;

129Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, PR China;

130Division of Oncology, Department of Pediatrics, Children’s Hospital of Philadelphia, Philadelphia, PA, USA;

131Department of Oncology, St. Jude Children’s Research Hospital, Memphis, TN, USA;

132Department of Pathology and Molecular Diagnostics, Nagoya City University, Nagoya, Japan;

133Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA;

134Department of Hematology and Rheumatology, Kagoshima University, Kagoshima, Japan;

135Department of Hematology, National Cancer Center Hospital, Tsukiji, Chuo-ku, Tokyo, Japan;

136Departments of Dermatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan;

137Department of Pathology, Seoul National University College of Medicine, Seoul, South Korea;

138Department of Pathology and Laboratory Medicine, Brown University Alpert School of Medicine, Providence, RI, USA;

139Department of Pathology, Japanese Red Cross Narita Hospital, Narita, Chiba, Japan;

140Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, UK;

141Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan;

142Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Nagoya, Japan;

143Department of Hematology, Amsterdam University Medical Centers, Amsterdam, The Netherlands;

144Department of Pathology, Seoul National University SNU SMG Boramae Hospital, Seoul, South Korea;

145Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany;

146Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre—UHN, Toronto, ON, Canada;

147Faculty of Medicine, University of Iceland, Reykjavik, Iceland;

148Institute of Cell Biology (Cancer Research), University of Duisburg-Essen, Essen, Germany;

149Department of Pathology, University of Ankara, School of Medicine, Ankara, Turkey;

150Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong, Hong Kong;

151Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA;

152Departement of Pathology, Institut Universitaire du cancer Toulouse Oncopole, Toulouse, France;

153Department of Hematology, Rennes University Hospital, Rennes, France;

154Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA;

155Radiation Oncology, Tata Memorial Centre, Mumbai, India;

156Department of Pathology, Yale School of Medicine, New Haven, CT, USA;

157Department of Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany;

158Pediatric Hematology/Oncology, Cell and Gene Therapy, Bambino Gesù Children’s Hospital, Rome, Italy;

159Division of Pathology, Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA;

160Hematology/Oncology, University of Virginia, Charlottesville, VA, USA;

161Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India;

162Department of Cellular Pathology, University College Hospital London, London, UK;

163Hematology Oncology, Cancer Institute Hospital of Japanese Foundation of Cancer Research, Tokyo, Japan;

164Department of Pathology, University Medical Centre Mannheim, Mannheim, Germany;

165Infections and Immunoepidemiology Branch, DCEG, National Cancer Institute, Rockville, MD, USA;

166Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, University Hospital Motol, Prague, The Czech Republic;

167Department of Anatomical Pathology, University of the Witwatersrand and National Health Laboratory Service, Johannesburg, South Africa;

168Laboratory of Pathology, National Cancer Institute/NIH, Bethesda, MD, USA;

169Department of Pathology, University of Utah, Salt Lake City, UT, USA;

170Department of Pathology, Kurume University, School of Medicine, Kurume, Japan;

171Department of Pathology, AP-HP, Hôpital Necker-Enfants Malades and Robert Debré, Université de Paris, Paris, France;

172Department of Pathology, Hospital Universitario de Toledo, Toledo, Spain;

173Department of Pathology, Saitama Medical University, Saitama Medical Center, Kawagoe, Japan;

174Department of Pediatrics, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan;

175Centre d’Immunologie de Marseille-Luminy, Inserm CNRS AMU, Marseille, France;

176Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan;

177Department of Neurosurgery, Kyorin University Faculty of Medicine, Tokyo, Japan;

178Department of Pathology, Tokai University School of Medicine, Isehara, Japan;

179Clinical Research, Saitama Children’s Medical Center, Saitama, Japan;

180Department of Histopathology, Royal Brompton & Harefield NHS Foundation Trust, London, UK;

181Department of Pathology, Hautepierre, University Hospital Strasbourg, Strasbourg, France;

182Department of Pathology, University of California San Francisco, San Francisco, CA, USA;

183Department of Pathology, University of Yamanashi, Chuo, Yamanashi, Japan;

184Department of Pathology, AP-HP, Hopitaux Universitaires Henri-Mondor, Creteil, France;

185Hemato-Oncology, Clinica Universidad de Navarra, Pamplona, Spain;

186Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden;

187Lab Haematology/Cytogenetics & Molecular Genetics, Tata Medical Center, Kolkata, India;

188Pathology Unit, Department of Molecular Medicine, University of Pavia, Pavia, Italy;

189Pediatric Development and Rehab, Genetics Division, Legacy Health/Randall Children’s Hospital and Washington State University Elson S. Floyd College of Medicine, Portland, OR, USA;

190Department of Pathology, Cincinnati Childrens Hospital Medical Center, Cincinnati, OH, USA;

191Experimental, Diagnostic and Specialty Medicine Department, Dermatology Unit, Bologna, Italy;

192Health Sciences, University of Florence Medical School, Florence, Italy;

193Pathology and Dermatology, The Ohio State University Medical Center, Columbus, OH, USA;

194Baylor College of Medicine, Texas Children’s Cancer Center, Houston, TX, USA;

195Internal Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria;

196Department of Medicine, Northwell Health Cancer Institute, New Hyde Park, NY, USA;

197Department of Pathology, Akershus University Hospital/University of Oslo, Lørenskog, Norway;

198Departamento de Diagnostico Laboratorial, IPOLFG—Servico de Anatomia Patologica, Lisboa, Portugal;

199Immunology and Microbiology, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA;

200Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden;

201Department of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland;

202Department of Anatomic Pathology and Histology, Fondazione Policlinico Universitario Agostino Gemelli-IRCCS, Rome, Italy;

203Department of Haematology, Plymouth University Medical School, Plymouth, UK;

204Department of Pathology and Laboratory Diagnostics, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland;

205Haematopathology, IRCCS Azienda Ospedaliero-Universitaria, Bologna, Italy;

206Paediatric Haematology and Oncology, Tata Translational Cancer Research Centre, Kolkata, India;

207Department of Hematology, University of Tsukuba, Ibaraki, Japan;

208Department of Dermatology, Asklepios Klinik St. Georg, Hamburg, Germany;

209Pathology and Dermatology, Hospital Obrero Nro 1 CNS, Hospital General, La Paz, Spain;

210Dept of Pathology and Dermatology, Wake Forest University, School of Medicine Medical Center Boulevard, Winston-Salem, NC, USA;

211Department of Health Sciences, Division of Histopathology and Molecular Diagnostics, University of Florence School of Human Health Sciences, Firenze, Italy;

212Department of Pathology, Okayama University Graduate School of Health Sciences, Okayama, Japan;

213Pathology and Laboratory Medicine, Phoenix Children’s Hospital, Phoenix, AZ, USA;

214Molecular Pathology Unit, Medical Faculty, Porto University, Porto, Portugal;

215Department of Hematology, Veneto Institute of Molecular Medicine, University of Padua, Padova, Italy;

216Department of Medicine, Division of Hematology, Stanford University, Palo Alto, CA, USA;

217Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan;

218Medicine and Quality Health Sciences, Mayo Clinic, Rochester, MN, USA;

219Department of Neuro-Oncology, University of Turin and City of Health and Science Hospital, Turin, Italy;

220Centre for Research and Technology Hellas, Institute of Applied Biosciences, Thessaloniki, Greece;

221Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada;

222Comprehensive Cancer Center Ulm (CCCU), Ulm University, Ulm, Germany;

223Department of Pathology, Chulalongkorn University, Bangkok, Thailand;

224Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan;

225Department of Pathology, Policlinico S.Orsola-Malpighi, Bologna, Italy;

226Pathology, Biomedical and Sciences, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan;

227Hematopathology Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India;

228Department of Medicine and Surgery, Institute of Hematology and Center for Hemato-Oncology Research, Perugia, Italy;

229Allergic Disease Research Center, Chutoen General Medical Center, Kakegawa, Japan;

230Hematology and Cell Therapy, CHU de Clermont-Ferrand, Clermont-Ferrand, France;

231Department of Medicine, Harvard Medical School, Boston, MA, USA;

232Hematology and Medical Oncology, Universitätsmedizin Göttingen, Göttingen, Germany;

233Department of Hematology, International Medical Center, Saitama Medical University, Hidaka, Japan;

234Myeloma Center, UAMS Winthrop P. Rockefeller Cancer Institute, Little Rock, AR, USA;

235Department of Haematology, Little Flower Hospital and Research Centre, Angamaly, India;

236Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands;

237Department of Pathology, Medipath and American Hospital of Paris, Paris, France;

238Division of Hematology Oncology, Indiana University, Indianapolis, IN, USA;

239Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA;

240Department of Pathology, University of California San Diego, San Diego, CA, USA;

241Department of Pathology, Fourth Military Medical University, Xi’an, PR China;

242Personalized Cancer Immunotherapy, Mie University Graduate School of Medicine, Tsu, Japan;

243Medical Department III, Ludwig-Maximilians-University (LMU) Hospital, Munich, Germany;

244Medical Oncology, Dana-Farber Cancer Institute and Havard Medical School, Boston, MA, USA;

245School of Basic and Medical Biosciences KCL, St. John’s Institute of Dermatology, London, UK;

246Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany;

247Department of Hematological Malignancies, Mie University Graduate School of Medicine, Tsu, Japan;

248Anatomic Pathology, Kyushu University, Fukuoka, Japan;

249Department of Pathology, Kobe City Medical Center General Hospital, Kobe, Japan;

250Department of Hematology, Peking University Peoples’ Hospital, Peking Institute of Hematology, Beijing, PR China;

251Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, WI, USA;

252Advanced Diagnosis, Nagoya Medical Center, Nagoya, Japan;

253Department of Pathology, Peking University Shenzhen Hospital, Shenzhen, PR China;

254Institute of Liver Studies, King’s College Hospital, London, UK;

255National Center of Translational Medicine, Institute of Hematology, Shanghai, PR China.